发明名称 |
Pharmaceutical combinations comprising a B-Raf inhibitor, an EGFR inhibitor and optionally a PI3K-alpha inhibitor |
摘要 |
A pharmaceutical combination comprising (a) a B-Raf inhibitor, (b) a EGFR inhibitor and, optionally, (c) a PI3K inhibitor; the uses of such combination in the treatment of proliferative diseases; and methods of treating a subject suffering from a proliferative disease comprising administering a therapeutically effective amount of such combination. |
申请公布号 |
AU2013299841(B2) |
申请公布日期 |
2016.11.24 |
申请号 |
AU20130299841 |
申请日期 |
2013.08.05 |
申请人 |
Novartis AG |
发明人 |
Caponigro, Giordano;Stuart, Darrin;Moutouh-de Parseval, Laure |
分类号 |
A61K31/506;A61K31/4439;A61K31/517;A61P35/00 |
主分类号 |
A61K31/506 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|